David W Parks

Title: David W Parks: Innovator in Drug Targeting Technologies

Introduction

David W Parks is a notable inventor based in Seattle, WA. He has made significant contributions to the field of drug targeting through his innovative approaches. His work focuses on enhancing the efficacy of drug delivery systems, particularly in the treatment of cancer and viral infections.

Latest Patents

David W Parks holds 1 patent for his invention titled "Covalent lipid-drug conjugates for drug targeting." This invention introduces a novel method of drug targeting that involves covalently binding a drug to a lipid carrier. The unique composition of these conjugates enhances the rate at which antineoplastic or antiviral drugs cross the plasma membrane. Additionally, it directs the drug within the cell to specific organelles, improving therapeutic outcomes. The versatility of these conjugates is further enhanced by the inclusion of a spacer group between the drug and the lipid, which can modulate drug release at the target site.

Career Highlights

David W Parks has built a career centered around innovative drug delivery systems. His work has been instrumental in advancing the field of pharmaceutical sciences. He is currently associated with the State of Oregon, where he continues to develop and refine his groundbreaking technologies.

Collaborations

David has collaborated with esteemed colleagues, including Milton Yatvin and Ronald W McClard. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in drug targeting technologies.

Conclusion

David W Parks is a pioneering inventor whose work in drug targeting has the potential to revolutionize treatment methodologies. His innovative approaches and collaborations highlight the importance of continued research in this vital area of healthcare.